Clinical Trials Directory

Trials / Completed

CompletedNCT03237221

Clinical Characteristics, Treatment and Prognosis of Chest Tightness Variant Asthma

Status
Completed
Phase
Study type
Observational
Enrollment
76 (actual)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
14 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Asthma, abbreviation for bronchial asthma, is one of the common chronic airways disease that threatens human health. Typical symptoms of asthma are recurrent wheezing, shortness of breath, chest tightness and cough, usually occurring at night or early morning. However, there are still some patients with only persistent clinical manifestations of chest tightness. Concerned about this group of patients, we presented a subgroup of bronchial asthma, namely, chest tightness variant asthma (CTVA). This asthma subgroup usually lacks asthma-specific clinical features such as wheezing, shortness of breath, wheezing, and therefore often misdiagnosed for a long time. In order to further understand the clinical characteristics, pathogenesis, and prognosis of patients with CTVA, we conducted a national multicenter observation study to further understand CTVA. Finally, we plan to clarify whether CTVA is a relatively independent asthma phenotype. Meanwhile, reducing misdiagnosis and perform an appropriate treatment of CTVA.

Conditions

Interventions

TypeNameDescription
DRUGTreat patient according to Global Initiative for Asthma (GINA) guidelineTreat patient according to Global Initiative for Asthma (GINA) guideline

Timeline

Start date
2015-03-01
Primary completion
2019-12-12
Completion
2020-10-23
First posted
2017-08-02
Last updated
2020-10-27

Locations

34 sites across 1 country: China

Source: ClinicalTrials.gov record NCT03237221. Inclusion in this directory is not an endorsement.